Retrophin Inc. Update Call Today's Calls 
Visit the TF Network Sites
Visit the TF Network Sites
· Corporate IR Center
· Institutional Investor Center
· Individual Investor Center
Download Plug-In
Real Player 8 Basic
Windows Media Player
Other Conference Calls
Other May 30 Calls
Today's Calls
Call Details
Retrophin Inc. Update Call
Scheduled to start Fri, May 30, 2014, 8:30 am Eastern

-- this event is ongoing now--
Listen to the ongoing live event audio stream

About Retrophin Inc (NasdaqGM:RTRX)Other Calls 
Retrophin, Inc., a biopharmaceutical company, focuses on the development, acquisition, and commercialization of therapies for the treatment of serious, catastrophic, or rare diseases. It sells Chenodal, a synthetic oral form of chenodeoxycholic acid for the treatment of radiolucent stones in well-opacifying gallbladders; and Vecamyl for the treatment of hypertension. The company develops Syntocinon Nasal Spray, an oxytocin nasal spray product for aiding milk let-down, as well as for the treatment of schizophrenia and autism; and RE-034, a synthetic hormone analogue that is composed of the first 24 amino acids of the 39 amino acids contained in the naturally occurring adrenocorticotrophic hormone for the treatment of infantile spasms and nephrotic syndrome. It also develops RE-024, a novel small molecule for the treatment of pantothenate kinase associated neurodegeneration; Sparsentan, a dual acting receptor antagonist of angiotensin and endothelin receptors for the treatment of focal segmental glomerulosclerosis; and RE-001, a therapy for the treatment of duchenne muscular dystrophy. In addition, the company intends to obtain FDA approval of Chenodal for the treatment of cerebrotendinous xanthomatosis; and for the treatment of patients with biliary cirrhosis. Retrophin, Inc. is based in New York, New York.

More Info: Quote | Profile | Research | Insider | Financials

Copyright © 2014 Yahoo! Inc. All Rights Reserved. Privacy Policy - Terms of Service
Copyright © 2014 FirstCall Events. Historical chart data provided by Commodity Systems, Inc. (CSI). Company profile information presented on this page is Copyright Capital IQ. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, CSI, etc.) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.